When does the weight loss plateau occur on drugs like Ozempic, and can you delay it?

Health & Lifestyle
206

Listen to article (english)

Translate to Spanish or other 102 languages!

When is a person likely to reach a weight loss plateau on GLP-1 agonists vs surgery vs dietary interventions? Image for illustration purposes
When is a person likely to reach a weight loss plateau on GLP-1 agonists vs surgery vs dietary interventions? Image for illustration purposes

Medical News Today

- Advertisement -
  • A new study investigated why different obesity treatments, including diets, surgeries and new medications like GLP-1 receptor agonists, such as semaglutide and tirzepatide, lead to varying times at which weight loss plateaus.
  • Utilizing a mathematical model, the research examines how these interventions alter the body’s regulation of energy intake and expenditure, affecting the duration of effective weight loss.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/when-does-the-loss-plateau-occur-on-drugs-like-ozempic-and-can-you-delay-it

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Vaccines for Family & Caregivers 
Next article
Weight-Loss Surgery Before Kidney Transplantation Improves Health & Eligibility of Patients with Obesity & Renal Failure

More Articles

Healthy Aging & Importance of Vaccinations Free Seminar, Nov. 6thin Edinburg

As people age, their immune systems become less effective, making it more difficult to fight off infections and disease. As a result, they face a greater risk of serious complications from illnesses such as influenza, pneumonia, shingles and respiratory syncytial virus (RSV).

STHS Bariatric Weight Loss Surgery Center Earns Center of Excellence Designation

Obesity is more than a weight concern. It’s a complex chronic disease that significantly increases the risk of serious health conditions, including heart disease, stroke, Type 2 diabetes and certain cancers. Left untreated, it can reduce quality of life and shorten life expectancy.

The Lifelong Quest for Women’s Heart Health

A new approach to women’s heart health may offer them a lifetime of opportunities.

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 
- Advertisement -